Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00410553
Status:
COMPLETED
Last Update Posted:
2018-10-03
First Post:
2006-12-11
Brief Title:
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2012-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-11
First Submit QC Date:
December 11 2006
Study First Post Date:
2006-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-02
Last Update Post Date:
2018-10-03
Last Update Post Date Type:
ACTUAL